Gelteq (GELS) Cash from Discontinued Operations (2023 - 2025)
Gelteq (GELS) posted quarterly Cash from Discontinued Operations of 700577.26 for Q4 2025, up 70.04% year-over-year from 411996.38 in Q4 2024, and up 70.04% quarter-over-quarter from 2338727.98 in Q4 2024.
Gelteq (GELS) Cash from Discontinued Operations (2023 - 2025) Analysis & Trends
Gelteq's Cash from Discontinued Operations history runs 3 years deep, the most recent figure standing at 700577.26 for Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Gelteq | 5.85 Mn | 5.58 Mn | - | -700,577.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -700,577.26 |
| Dec 31, 2025 | -700,577.26 |
| Dec 31, 2024 | -2.34 Mn |
| Dec 31, 2024 | -2.34 Mn |
| Dec 31, 2023 | -279,298.35 |
| Dec 31, 2023 | -279,298.35 |